Dactinomycin – Cancer Treatment

Dactinomycin is an antineoplastic antibiotic used for the treatment of various types of cancer, including Wilms tumor, rhabdomyosarcoma, choriocarcinoma, and testicular cancer. Dactinomycin works by inhibiting RNA synthesis in tumor cells, slowing their growth and promoting their destruction. The medication is administered intravenously under medical supervision and is typically used as part of combination chemotherapy regimens. Dactinomycin may cause side effects such as nausea, vomiting, hair loss, and blood count changes, requiring regular medical monitoring for patients. This drug is included in the WHO List of Essential Medicines and is an important component in the treatment of oncological diseases in both children and adults.